US 12297279
Compositions and methods for treating pain in subjects with rheumatoid arthritis
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 12297279 (Compositions and methods for treating pain in subjects with rheumatoid arthritis) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K9/0019, A61P